Additionally, in a study conducted by Vausort et al. [35], LEF1-AS1-202 expression levels were measured in 104 mild COVID-19 patients during the acute phase; the patients were then stratified for the presence or absence of long COVID symptoms reported at 12 months from the acute illness. The gene discussed is LEF1; the disease is COVID-19.